Aromatics
- An estrogen receptor antagonist, Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women. It is administered intramuscularly. Reference standards of Fulvestrant API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => (7R,8R,9S,13S,14S,17S)-13-Methyl-7-(9-((4,4,5,5,6,6,7,7,7-nonafluoroheptyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
[catalogue_number] => PA 06 54540
[category_ids] => ,92,78,70,82,89,88,80,
[chemical_name] =>
[weight] => 706.79
[form] => C34H47F9O3S
[cas] => NA
[pslug] => 7r-8r-9s-13s-14s-17s-13-methyl-7-9-4-4-5-5-6-6-7-7-7-nonafluoroheptyl-sulfinyl-nonyl-7-8-9-11-12-13-14-15-16-17-decahydro-6h-cyclopenta-a-phenanthrene-3-17-diol-pa0654540
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
stdClass Object
(
[pname] => Fulvestrant System Suitability Mixture
[catalogue_number] => PA 06 0541008
[category_ids] => ,80,71,76,75,93,78,70,82,
[chemical_name] =>
[weight] => 606.78
[form] => C32H47F5O3S
[cas] => NA
[pslug] => fulvestrant-system-suitability-mixture-pa060541008
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
